首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >Analysis of combined HDR Brachytherapy and external beam radiotherapy in the treatment of carcinoma of cervix.
【24h】

Analysis of combined HDR Brachytherapy and external beam radiotherapy in the treatment of carcinoma of cervix.

机译:HDR近距离放射疗法与外照射疗法联合治疗宫颈癌的分析。

获取原文

摘要

This study is designed to evaluate dosimetric and radiobiological aspects of the treatments of carcinoma of cervix treated with HDR brachytherapy in combination of external beam radiotherapy. 49 patients with carcinoma of cervix treated with external beam radiotherapy plus HDR brachytherapy were included in the analysis. FIGO classification was used for staging of the tumor and were of stage U - IIIB. ICRU-38 definitions of dose points specifications were used to determine doses and BED values at different points. Some other points, for bladder and rectum have also been defined during the planning of these patients to see their relevance in planning and reporting and found that the bladder and rectum complications have significant correlation with BED values of the points which have received higher dose. The ICRU reference volume, calculated with respect to the point A dose, had positive correlation with locoregional control and is a good predictor in 2D planning done with orthogonal films. The doses and corresponding BEDs at different point of lymphatic trapezoid do not reveal any correlation with neither complication nor with local control. The ICRU bladder and rectum reference points do not have any bearing with complications hence cannot be considered as good predictors. While on the other hand the ICRU reference volume calculated with respect to the point A dose and corresponding tumor control probability have positive correlation with clinical outcome hence is considered to be a good clinical predictor.
机译:本研究旨在评估HDR近距离放射疗法结合外照射放射疗法治疗宫颈癌的剂量学和放射生物学方面。分析包括49例接受了外部束放射疗法加HDR近距离放射疗法治疗的宫颈癌患者。 FIGO分类用于肿瘤分期,并且处于U-IIIB期。剂量点规格的ICRU-38定义用于确定不同点的剂量和BED值。在计划这些患者的过程中,还为膀胱和直肠定义了一些其他要点,以了解他们在计划和报告中的相关性,并发现膀胱和直肠并发症与已接受更高剂量的这些点的BED值具有显着相关性。相对于A点剂量计算出的ICRU参考体积与局部控制呈正相关,并且在正交胶卷进行的2D规划中是很好的预测指标。淋巴梯形的不同点处的剂量和相应的BED与并发症和局部控制均无相关性。 ICRU膀胱和直肠参考点没有任何并发​​症,因此不能被视为良好的预测指标。另一方面,关于A点剂量计算的ICRU参考体积和相应的肿瘤控制概率与临床结果呈正相关,因此被认为是良好的临床预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号